Literature DB >> 25905855

Racial/Ethnic and socioeconomic disparities in endocrine therapy adherence in breast cancer: a systematic review.

Megan C Roberts1, Stephanie B Wheeler, Katherine Reeder-Hayes.   

Abstract

We examined the current literature to understand factors that influence endocrine therapy (ET) adherence among racial/ethnic and socioeconomic subpopulations of breast cancer patients. We searched PubMed and PsycINFO databases for studies from January 1, 1978, to June 20, 2014, and January 1, 1991, to June 20, 2014, respectively, and hand-searched articles from relevant literature reviews. We abstracted and synthesized results within a social ecological framework. Fourteen articles met all inclusion criteria. The majority of included articles reported significant underuse of ET among minority and low-income women. Modifiable intrapersonal, interpersonal, and community-level factors are associated with ET use, and these factors vary across subgroups. Both race/ethnicity and socioeconomic status are associated with ET use in most settings. Variation in factors associated with ET use across subgroups indicates the need for more nuanced research and targeted interventions among breast cancer patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25905855      PMCID: PMC4455526          DOI: 10.2105/AJPH.2014.302490

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  78 in total

1.  Breast cancer posttreatment surveillance: diagnosis and management of recurrent disease.

Authors:  Amer K Karam
Journal:  Clin Obstet Gynecol       Date:  2011-03       Impact factor: 2.190

2.  Racial differences in medication adherence: A cross-sectional study of Medicare enrollees.

Authors:  Ben S Gerber; Young Ik Cho; Ahsan M Arozullah; Shoou-Yih D Lee
Journal:  Am J Geriatr Pharmacother       Date:  2010-04

3.  Racial disparities in initiation of adjuvant endocrine therapy of early breast cancer.

Authors:  Katherine E Reeder-Hayes; Anne Marie Meyer; Stacie B Dusetzina; Huan Liu; Stephanie B Wheeler
Journal:  Breast Cancer Res Treat       Date:  2014-05-01       Impact factor: 4.872

4.  The Impact of Breast Care Nurses on Patients' Satisfaction, Understanding of the Disease, and Adherence to Adjuvant Endocrine Therapy.

Authors:  Ute-Susann Albert; Cosima Zemlin; Peymann Hadji; Volker Ziller; Barbara Kuhler; Birgit Frank-Hahn; Uwe Wagner; Matthias Kalder
Journal:  Breast Care (Basel)       Date:  2011-06-03       Impact factor: 2.860

Review 5.  Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapy.

Authors:  Peyman Hadji
Journal:  Crit Rev Oncol Hematol       Date:  2009-03-18       Impact factor: 6.312

6.  Disparities in medical care among commercially insured patients with newly diagnosed breast cancer: opportunities for intervention.

Authors:  Louise J Short; Maxine D Fisher; Peter M Wahl; Monique B Kelly; Grant D Lawless; Sandra White; Nancy A Rodriguez; Vincent J Willey; Otis W Brawley
Journal:  Cancer       Date:  2010-01-01       Impact factor: 6.860

7.  Missed opportunities: racial disparities in adjuvant breast cancer treatment.

Authors:  Nina A Bickell; Jason J Wang; Soji Oluwole; Deborah Schrag; Henry Godfrey; Karen Hiotis; Jane Mendez; Amber A Guth
Journal:  J Clin Oncol       Date:  2006-03-20       Impact factor: 44.544

8.  Initial treatment and changes in adjuvant endocrine therapy for early stage breast cancer.

Authors:  Lee S Schwartzberg; Patrick Cobb; Frank Senecal; David Henry; Kimary Kulig; Mark S Walker; Arthur C Houts; Edward J Stepanski
Journal:  Breast       Date:  2009-04-01       Impact factor: 4.380

9.  Adherence to adjuvant hormone therapy in low-income women with breast cancer: the role of provider-patient communication.

Authors:  Yihang Liu; Jennifer L Malin; Allison L Diamant; Amardeep Thind; Rose C Maly
Journal:  Breast Cancer Res Treat       Date:  2012-12-23       Impact factor: 4.872

10.  Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer.

Authors:  L Huiart; S Dell'Aniello; S Suissa
Journal:  Br J Cancer       Date:  2011-04-26       Impact factor: 7.640

View more
  45 in total

1.  Patient and provider perspectives on delivery of oral cancer therapies.

Authors:  Caitlin C Murphy; Simon J Craddock Lee; David E Gerber; John V Cox; Hannah M Fullington; Robin T Higashi
Journal:  Patient Educ Couns       Date:  2019-06-20

Review 2.  Racial disparities, cancer and response to oxidative stress.

Authors:  Jie Zhang; Zhi-Wei Ye; Danyelle M Townsend; Chanita Hughes-Halbert; Kenneth D Tew
Journal:  Adv Cancer Res       Date:  2019-04-23       Impact factor: 6.242

3.  Racial and geographic disparities in adherence and discontinuation to adjuvant endocrine therapy in Texas Medicaid-insured patients with breast cancer.

Authors:  Albert J Farias; Wen-Hsing Wu; Xianglin L Du
Journal:  Med Oncol       Date:  2018-06-20       Impact factor: 3.064

4.  High Initiation of Adjuvant Hormonal Therapy Among Uninsured Stages I-III Breast Cancer Patients Treated in a Safety-Net Healthcare System.

Authors:  Caitlin C Murphy; Jasmin A Tiro; Gary W Jean; Bijal A Balasubramian; Carlos A Alvarez
Journal:  J Womens Health (Larchmt)       Date:  2017-03-15       Impact factor: 2.681

5.  Financial Impact of Breast Cancer in Black Versus White Women.

Authors:  Stephanie B Wheeler; Jennifer C Spencer; Laura C Pinheiro; Lisa A Carey; Andrew F Olshan; Katherine E Reeder-Hayes
Journal:  J Clin Oncol       Date:  2018-04-18       Impact factor: 44.544

6.  Association Between Out-Of-Pocket Costs, Race/Ethnicity, and Adjuvant Endocrine Therapy Adherence Among Medicare Patients With Breast Cancer.

Authors:  Albert J Farias; Xianglin L Du
Journal:  J Clin Oncol       Date:  2016-10-28       Impact factor: 44.544

7.  Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing.

Authors:  Megan C Roberts; Morris Weinberger; Stacie B Dusetzina; Michaela A Dinan; Katherine E Reeder-Hayes; Melissa A Troester; Lisa A Carey; Stephanie B Wheeler
Journal:  Breast Cancer Res Treat       Date:  2015-07-28       Impact factor: 4.872

8.  Racial differences in receipt of adjuvant hormonal therapy among Medicaid enrollees in South Carolina diagnosed with breast cancer.

Authors:  Tisha M Felder; D Phuong Do; Z Kevin Lu; Lincy S Lal; Sue P Heiney; Charles L Bennett
Journal:  Breast Cancer Res Treat       Date:  2016-04-27       Impact factor: 4.872

Review 9.  Understanding and effectively addressing breast cancer in African American women: Unpacking the social context.

Authors:  David R Williams; Selina A Mohammed; Alexandra E Shields
Journal:  Cancer       Date:  2016-02-29       Impact factor: 6.860

10.  Factors Associated with Endocrine Therapy Non-Adherence in Breast Cancer Survivors.

Authors:  Jennifer C Spencer; Bryce B Reeve; Melissa A Troester; Stephanie B Wheeler
Journal:  Psychooncology       Date:  2020-02-11       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.